In the BioHarmony Drug Report Database
Torsemide
Demadex, Soaanz (torsemide) is a small molecule pharmaceutical. Torsemide was first approved as Demadex on 1993-08-23. It is used to treat ascites, chronic kidney failure, edema, heart failure, and hypertension amongst others in the USA. Torsemide’s patent is valid until 2033-10-06 (FDA).
Trade Name
|
Demadex, Soaanz |
|---|---|
Common Name
|
torsemide |
ChEMBL ID
|
CHEMBL1148 |
Indication
|
ascites, chronic kidney failure, edema, heart failure, hypertension, liver cirrhosis, nephrotic syndrome, pulmonary edema |
Drug Class
|
Diuretics (furosemide type) |
Image (chem structure or protein)